期刊文献+

气相色谱-质谱法测定血浆中双氯芬酸钠的含量 被引量:2

GC-MS Determination of Sodium Diclofenac in Human Plasma
在线阅读 下载PDF
导出
摘要 提出了应用气相色谱-质谱法测定血浆中双氯芬酸钠含量。血浆样品中双氯芬酸钠经盐酸提取,并加入三甲基硅烷衍生化试剂进行衍生化,所得衍生化产物经萃取、净化后供气相色谱分离及质谱测定。采用选择离子质谱扫描方式,供试品双氯芬酸钠-三甲基硅烷衍生物定量选择离子检测质荷比为m/z367,内标物布洛芬-三甲基硅烷衍生物定量选择离子检测质荷比为m/z263。双氯芬酸钠的线性范围为0.005~5.0mg·mL-1,检出限(3S/N)为0.5μg.L-1。方法回收率在94.6%~97.4%之间,日内、日间相对标准偏差(n=6)均小于5%。 The method of C-C-MS was applied to the determination of sodium diclofenac in human plasma. The sample containing sodium diclofenac was acidified with HCl and derivatized with trimethylsilane. The derivatized product was extracted and purified, which was then used for GC-MS determination. The selected ion monitoring mode and values of m/z of 367 for diclofenac derivative and m/z of 263 for ibuprofen derivative (internal standrad) were adopted in the MS determination. Linearity range of sodium diclofenac was found between 0. 005- 5.0 mg · L^-1 , with detection limit (3S/N) of 0. 5 μg · L^-1. The values of recovery were found in the range of 94. 6%-97. 4%, with values of intraday and interday RSD's less than 5%.
出处 《理化检验(化学分册)》 CAS CSCD 北大核心 2010年第2期153-155,共3页 Physical Testing and Chemical Analysis(Part B:Chemical Analysis)
关键词 气相色谱-质谱法 双氯芬酸钠 血浆 三甲基硅烷 GC-MS Sodium diclofenac Plasma TMS
  • 相关文献

参考文献8

  • 1ROSKAR R, KMETEC V. Liquid chromatographic determination of diclofenac in human synovial fluid [J]. J Chromatogr B, 2003,788: 57-59.
  • 2FARRE M, PETROVIC M, BARCELO Do Recently developed GC-MS and LC/MS methods for determining NSAIDs in water samples [J]. Anal Bioanal Chem, 2007,387:1203-1205.
  • 3林伟丰,康信煌,陈缵光,李全文,杨琳,蔡沛祥.毛细管电泳法测定血清中的双氯芬酸钠[J].中山大学学报(自然科学版),2005,44(6):58-60. 被引量:4
  • 4LALA L G, D'MELLO P M, NAIK S R. HPTLC determination of diclofenac sodium from serum[J]. J Pharm Biomed Anal, 2002,29 : 539-540.
  • 5阳利龙,祝文兵,张毕奎,朱运贵,刘晓磊.固相萃取-HPLC法测定人血浆中双氯芬酸钠的浓度[J].中国药房,2007,18(8):594-596. 被引量:1
  • 6MICHAEL R B, XUE Yu-zhu, Stephen Cooper, et al. Sensitive capillary gas chromatographic-mass spectrometric-selected-ion monitoring method for the determination of diclofenac concentrations in human plasma[J]. J Chromatogr B, 1995,685:59-61.
  • 7HAJ B M E, AINRI A M A, HASSAN M H, et al. The GC-MS analysis of some commonly used non-steriodal anti-inflammatory drugs (NSAIDs) in pharma- ceutical dosage forms and in urine[J]. Forensic Science International, 1999,105 : 141-143.
  • 8KAPHALIA L, KAPHALIA B S, KUMAR S, et al. Efficient high performance liquid chromatograph/ultraviolet method for determination of diclofenac and 4'- hydroxydielofenac in rat serum[J]. J Chromatogr B, 2006,830 : 231-233.

二级参考文献14

共引文献3

同被引文献37

  • 1国家药典委员会.中华人民共和国药典(二部)[S].2005年版.北京:化学工业出版社,2005:附录83-90.
  • 2国家药典委员会.中华人民共和国药典(二部)[S].2000年版北京:化学工业出版社,2000:321,750.
  • 3DAWlDOWICZ Andrzej L., KONDZIOLA Krzysztof, KOBIELSKI Mateusz. Determination of Free Indomethacin in Human Plasma Using HPLC with UV Detection [J].Journal of liquid chromatography & related technologies, 2009, 32(17-20) :2686-2698.
  • 4Koichi Suenami, Lee Wah Lira L, Toyohide Takeuchi et al.Rapid and simultaneous determination of nonsteroidal anti-inflammatory drugs in human plasma by LC-MS with solid-phase extraction [JJ. Anal Bioanal Chem, 2006, 384 : 1501-1505.
  • 5European Pharmacopiea 6.0.European Pharmacopoeial Convention. 2007.
  • 6U.S.Pharmacopeia 32/National Formulary 27.The United States Pharmacopeial Convention. 2008.
  • 7Silvana E. Vignaduzzo, Patricia M. Castellano, Teodoro S. Kaufman a, b. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations [J].Journal of Pharmaceutical and Biomedical Analysis, 2008, (46) : 219-225.
  • 8Lee HS, Kang IM, Lee HW, Seo JH, Ryu JH, Choi SJ, Lee MJ, De- velopment and validation of a high performance liquid chromatography-tandem mass spectrometry for the determination of etodolac in human plasma [J].Chromatogr B Analyt Technol Biomed Life Sci, 2008, 863 (1) : 158-162.
  • 9A. Mosrafa shegata, N. Y. Hassan, A. S. Fayed, B. A. EI-Zeany. Derivative spectrophotometric and fluorimetric methods for determination of rofecoxib in tablets and in human plasma in presence of its photodegradation product [J]. I1 Farmaco, 2004, 59(2) : 139-145.
  • 10Natalia Navas, Roeio Ure a and Luis-Fermin Capitan-Vallvey. Determination of Celeeoxib, Rofecoxib, Sodium Diclofenac and Niflu-mie Acid in Human Serum Samples by HPLC with DAD Detection [J]. Chromatographia, 2008 (67), 55-61.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部